← Back

SYKStryker

$275.56+2.06%Real quote · delayedOrthopedic devicesMedtech & life sciences · 10 peers →

🏛️ Company factsSEC filings + FINRA official data

Annual revenue $7.2B · latest quarter up 9.4% YoY · profitable (FY net income $849M) · short activity below its recent average — bears covering.

FY revenue

$7.2B

2025-12

Latest Q YoY

+9.4%

Gross margin

18.4%

FY net income

$849M

Diluted EPS

$2.21

Short volume

19.9%

20d avg 45.5% · shorts covering

🐋 5%+ ownership filings (last 180d)

The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.

2026-04-30passive (13G)VANGUARD CAPITAL MANAGEMENT LLC
2026-04-14activist (13D)STRYKER RONDA E
2026-03-27passive (13G)VANGUARD GROUP INC

🎯 Market expectations

Expectation reliability High · 77/100

Nasdaq analyst consensus · the pre-news baseline

Next quarter (Sep 2026) consensus$3.62Estimate range $3.50 ~ $3.77 · 8 analystsRevisions (4w):↓1

History: actual vs consensusavg -0.7%

Jun 2026$3.69 vs $3.46+6.65%
Mar 2026$2.60 vs $2.98-12.75%
Dec 2025$4.47 vs $4.40+1.59%
Sep 2025$3.19 vs $3.14+1.59%

The takeaway

It has tracked consensus closely — no systematic over- or under-shooting.

Analyst estimates, not our forecast · not investment advice

What's moving this stock lately

No recent news affecting this stock

🕰️ Price × news · engine report card

Drag to pan, scroll to zoom · real daily bars and volume

The 4 engine calls on this chart (hit / miss / pending) are Pro — price and volume only for now▂ volume

📜 Call history (newest first

🔒 Pro only

4 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view

🔒 Pro only

Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.